dc.contributor.author | EADV Task Force on Quality of Life | |
dc.contributor.author | Finlay, A Y | |
dc.contributor.author | Salek, M S | |
dc.contributor.author | Abeni, D | |
dc.contributor.author | Tomás-Aragonés, L | |
dc.contributor.author | van Cranenburgh, O D | |
dc.contributor.author | Evers, A W M | |
dc.contributor.author | Jemec, G B E | |
dc.contributor.author | Linder, D | |
dc.contributor.author | Manolache, L | |
dc.contributor.author | Marrón, S E | |
dc.contributor.author | Prinsen, C A C | |
dc.contributor.author | Susitaival, P | |
dc.contributor.author | Chernyshov, P V | |
dc.date.accessioned | 2020-07-09T00:06:06Z | |
dc.date.available | 2020-07-09T00:06:06Z | |
dc.date.issued | 2017-03 | |
dc.identifier.citation | EADV Task Force on Quality of Life , Finlay , A Y , Salek , M S , Abeni , D , Tomás-Aragonés , L , van Cranenburgh , O D , Evers , A W M , Jemec , G B E , Linder , D , Manolache , L , Marrón , S E , Prinsen , C A C , Susitaival , P & Chernyshov , P V 2017 , ' Why quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Life ' , Journal of the European Academy of Dermatology and Venereology , vol. 31 , no. 3 , pp. 424-431 . https://doi.org/10.1111/jdv.13985 | |
dc.identifier.issn | 0926-9959 | |
dc.identifier.uri | http://hdl.handle.net/2299/22943 | |
dc.description | © 2016 European Academy of Dermatology and Venereology. | |
dc.description.abstract | The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures. | en |
dc.format.extent | 8 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of the European Academy of Dermatology and Venereology | |
dc.subject | Clinical Decision-Making | |
dc.subject | Communication | |
dc.subject | Cost of Illness | |
dc.subject | Dermatology/organization & administration | |
dc.subject | Humans | |
dc.subject | Patient Comfort | |
dc.subject | Physician-Patient Relations | |
dc.subject | Prognosis | |
dc.subject | Quality of Life | |
dc.subject | Referral and Consultation | |
dc.subject | Skin Diseases/complications | |
dc.subject | Surveys and Questionnaires | |
dc.title | Why quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Life | en |
dc.contributor.institution | Department of Clinical and Pharmaceutical Sciences | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | Public Health and Patient Safety Unit | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.description.status | Peer reviewed | |
dc.identifier.url | http://orca.cf.ac.uk/101667/ | |
rioxxterms.versionofrecord | 10.1111/jdv.13985 | |
rioxxterms.type | Other | |